97 related articles for article (PubMed ID: 7741102)
1. Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells.
Johnston JB; Dalal BI; Israels SJ; Oh S; McMillan E; Begleiter A; Michaud G; Israels LG; Greenberg AH
Am J Clin Pathol; 1995 May; 103(5):574-82. PubMed ID: 7741102
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
5. Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.
Rameshwar P; Chang VT; Thacker UF; Gascón P
Am J Hematol; 1998 Oct; 59(2):133-42. PubMed ID: 9766798
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis.
Martyré MC; Romquin N; Le Bousse-Kerdiles MC; Chevillard S; Benyahia B; Dupriez B; Demory JL; Bauters F
Br J Haematol; 1994 Sep; 88(1):9-16. PubMed ID: 7803262
[TBL] [Abstract][Full Text] [Related]
7. Role of transforming growth factor-beta in chronic lymphocytic leukemia.
Israels LG; Israels SJ; Begleiter A; Verburg L; Schwartz L; Mowat MR; Johnston JB
Leuk Res; 1993 Jan; 17(1):81-7. PubMed ID: 8429683
[TBL] [Abstract][Full Text] [Related]
8. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
10. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis.
Schmitt A; Jouault H; Guichard J; Wendling F; Drouin A; Cramer EM
Blood; 2000 Aug; 96(4):1342-7. PubMed ID: 10942376
[TBL] [Abstract][Full Text] [Related]
11. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
[TBL] [Abstract][Full Text] [Related]
12. Periostin and bone marrow fibrosis.
Oku E; Kanaji T; Takata Y; Oshima K; Seki R; Morishige S; Imamura R; Ohtsubo K; Hashiguchi M; Osaki K; Yakushiji K; Yoshimoto K; Ogata H; Hamada H; Izuhara K; Sata M; Okamura T
Int J Hematol; 2008 Jul; 88(1):57-63. PubMed ID: 18465194
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1
Arciprete F; Verachi P; Martelli F; Valeri M; Balliu M; Guglielmelli P; Vannucchi AM; Migliaccio AR; Zingariello M
Exp Hematol; 2023 May; 121():30-37. PubMed ID: 36863479
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia with marrow fibrosis at initial presentation: possible involvement of transforming growth factor-beta(1).
Mori A; Wada H; Okada M; Takatsuka H; Tamura A; Fujimori Y; Okamoto T; Takemoto Y; Kanamaru A; Kakishita E
Acta Haematol; 2000; 103(4):220-3. PubMed ID: 11014898
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and histological analysis of bone marrow collagen in myelofibrosis.
Charron D; Robert L; Couty MC; Binet JL
Br J Haematol; 1979 Feb; 41(2):151-61. PubMed ID: 427028
[TBL] [Abstract][Full Text] [Related]
16. Splenic marginal zone lymphoma presenting as myelofibrosis associated with bone marrow involvement of lymphoma cells which secrete a large amount of TGF-beta.
Matsunaga T; Takemoto N; Miyajima N; Okuda T; Nagashima H; Sato T; Terui T; Sasaki H; Ohmi N; Hirayama Y; Tamura Y; Niitsu Y
Ann Hematol; 2004 May; 83(5):322-5. PubMed ID: 15060752
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profile in acute myelofibrosis associated with aggressive large granular lymphocyte leukemia.
Dalal BI; Keown PA; Paraskevas F; Williams G; Johnston JB
Am J Hematol; 1995 Aug; 49(4):349-52. PubMed ID: 7639282
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of stroma in human immunodeficiency virus/acquired immunodeficiency syndrome-affected bone marrows and correlation with CD4 counts.
O'Malley DP; Sen J; Juliar BE; Orazi A
Arch Pathol Lab Med; 2005 Sep; 129(9):1137-40. PubMed ID: 16119986
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules.
Fava RA; Casey TT; Wilcox J; Pelton RW; Moses HL; Nanney LB
Blood; 1990 Nov; 76(10):1946-55. PubMed ID: 2242422
[TBL] [Abstract][Full Text] [Related]
20. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis.
Terui T; Niitsu Y; Mahara K; Fujisaki Y; Urushizaki Y; Mogi Y; Kohgo Y; Watanabe N; Ogura M; Saito H
Blood; 1990 Apr; 75(7):1540-8. PubMed ID: 2317561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
